Serum-free placental growth factor isoform 1 at 11–13-week gestation: effects of maternal factors, mean arterial pressure, placental volume, and uterine artery pulsatility index

References

• Nicolaides KH. A model for a new pyramid of prenatal care based on the 11 to 13 weeks’ assessment. Prenat Diagn. 2011;31(1):3–6.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Syngelaki A, Sarquis R, et al. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat Diagn. 2011;31(1):66–74.
   PubMed Web of Science ®Google Scholar
• Rizzo G, Capponi A, Cavicchioni O, et al. First trimester uterine Doppler and three-dimensional ultrasound placental volume calculation in predicting pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2008;138(2):147–151.
   PubMed Web of Science ®Google Scholar
• Vuorela P, Hatva E, Lymboussaki A, et al. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod. 1997;56(2):489–494.
   PubMed Web of Science ®Google Scholar
• Poon LC, Zaragoza E, Akolekar R, et al. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Prenat Diagn. 2008;28(12):1110–1115.
   PubMed Web of Science ®Google Scholar
• Zaragoza E, Akolekar R, Poon LC, et al. Maternal serum placental growth factor at 11–13 weeks in chromosomally abnormal pregnancies. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2009;33(4):382–386.
   PubMed Web of Science ®Google Scholar
• Wright D, Akolekar R, Syngelaki A, et al. A competing risks model in early screening for preeclampsia. Fetal Diagn Ther. 2012;32(3):171–178.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Syngelaki A, Poon L, et al. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33(1):8–15.
   PubMed Web of Science ®Google Scholar
• O’Gorman N, Wright D, Syngelaki A, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks gestation. Am J Obstet Gynecol. 2016;214(1):103.e1–103.e12.
   PubMed Web of Science ®Google Scholar
• Wright D, Syngelaki A, Akolekar R, et al. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol. 2015;213(1):62.e1–62.e10.
   Web of Science ®Google Scholar
• Chappell LC, Duckworth S, Seed PT, et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation. 2013;128(19):2121–2131.
   PubMed Web of Science ®Google Scholar
• Redman C, Lodge T, Meacher H, et al. Triage PlGF test: point-of-care assay of plasma placental growth factor to diagnose preeclampsia. Adv Perinat Med. 2010:181–185. (Proceedings (ECPM)).
   Google Scholar
• Nucci M, Poon LC, Demirdjian G, et al. Maternal serum placental growth factor isoforms 1 and 2 at 11–13, 20–24 and 30–34 weeks’ gestation in late-onset pre-eclampsia and small for gestational age neonates. Fetal Diagn Ther. 2014;35(4):249–257.
   PubMed Web of Science ®Google Scholar
• Manthati S, Pratumvinit B, Hanyongyuth R, et al. Circulating free soluble fms-like tyrosine kinase-1 during late first trimester in relation with placental volume as a surrogate for trophoblastic production: a physiology study in low-risk cohort. J Matern Fetal Neonatal Med. 2017;30(16):1976–1983.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Chaemsaithong P, Yeo L, et al. Pre-eclampsia Part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466–480.
   PubMed Web of Science ®Google Scholar
• Poon LC, Zymeri NA, Zamprakou A, et al. Protocol for measurement of mean arterial pressure at 11–13 weeks’ gestation. Fetal Diagn Ther. 2012;31(1):42–48.
   PubMed Web of Science ®Google Scholar
• Robinson HP. The diagnosis of early pregnancy failure by sonar. Br J Obstet Gynaecol. 1975;82(11):849–857.
   PubMedGoogle Scholar
• Wataganara T, Metzenbauer M, Peter I, et al. Placental volume, as measured by 3-dimensional sonography and levels of maternal plasma cell-free fetal DNA. Am J Obstet Gynecol. 2005;193(2):496–500.
   PubMed Web of Science ®Google Scholar
• Plasencia W, Maiz N, Bonino S, et al. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2007;30(5):742–749.
   PubMed Web of Science ®Google Scholar
• Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20(1):IX–XIV.
   PubMed Web of Science ®Google Scholar
• Tsiakkas A, Duvdevani N, Wright A, et al. Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2015;45(5):591–598.
   PubMed Web of Science ®Google Scholar
• Pandya P, Wright D, Syngelaki A, et al. Maternal serum placental growth factor in prospective screening for aneuploidies at 8–13 weeks’ gestation. Fetal Diagn Ther. 2012;31(2):87–93.
   PubMed Web of Science ®Google Scholar
• Lai J, Garcia-Tizon Larroca S, Peeva G, et al. Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30–33 weeks’ gestation. Fetal Diagn Ther. 2014;35(4):240–248.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683.
   PubMed Web of Science ®Google Scholar
• Taylor RN, Grimwood J, Taylor RS, et al. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol. 2003;188(1):177–182.
   PubMed Web of Science ®Google Scholar
• Benton SJ, Hu Y, Xie F, et al. Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction? Am J Obstet Gynecol. 2012;206(2):163.e1–163.e7.
   Web of Science ®Google Scholar
• Nucci M, Poon LC, Demirdjian G, et al. Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11–13 weeks’ gestation in normal and pathological pregnancies. Fetal Diagn Ther. 2014;36(2):106–116.
   PubMed Web of Science ®Google Scholar
• Hafner E, Metzenbauer M, Dillinger-Paller B, et al. Correlation of first trimester placental volume and second trimester uterine artery Doppler flow. Placenta. 2001;22(8–9):729–734.
   PubMed Web of Science ®Google Scholar
• Schwartz N, Sammel MD, Leite R, et al. First-trimester placental ultrasound and maternal serum markers as predictors of small-for-gestational-age infants. Am J Obstet Gynecol. 2014;211(3):253.e1–253.e8.
   Web of Science ®Google Scholar
• Spencer K, Bindra R, Cacho AM, et al. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Prenat Diagn. 2004;24(3):169–173.
   PubMed Web of Science ®Google Scholar
• Spencer K, Heath V, El-Sheikhah A, et al. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn. 2005;25(5):365–369.
   PubMed Web of Science ®Google Scholar
• Committee Opinion No. 638: first-trimester risk assessment for early-onset preeclampsia. Obstet Gynecol. 2015;126(3):e25–e27.
   PubMed Web of Science ®Google Scholar